Latest Research Reports

Report: Acute myeloid leukaemia market to grow at CAGR of 14% by 2026

The acute myeloid leukaemia (AML) market is expected to triple from $406m in 2016 to more than $1.5bn by 2026, recording a compound annual growth rate (CAGR) of 14%, according to a report...

Report: Acute myeloid leukaemia market to grow at CAGR of 14% by 2026

Report: Global HER2-positive breast cancer market set to witness CAGR of 4.4%

The global human epidermal growth factor receptor type 2 (HER2)-positive breast cancer market is projected to grow from $6.4bn in 2015 to $9.89bn in 2025, witnessing a compound annual growth...

Report: Global HER2-positive breast cancer market set to witness CAGR of 4.4%

CGRP Antagonists forecast to dominate migraine market by 2026

CGRP Antagonists forecast to dominate migraine market by 2026

Report: Haemophilia A and B market set to reach $8bn by 2026

The haemophilia A and B market is projected to grow from $6.7bn in 2016 to $8bn in 2026 at a compound annual growth rate of 1.8%, according to a report by...

Report: Haemophilia A and B market set to reach $8bn by 2026

AbbVie’s Humira sales continue to climb beyond its patent expiration

AbbVie’s Humira sales continue to climb beyond its patent expiration

Top ten selling products of atrial fibrillation

Top ten selling products of atrial fibrillation

Generic sales erosion in neurology: the bigger they are, the harder they fall

Generic sales erosion in neurology: the bigger they are, the harder they fall

Risk of Venous thromboembolism higher in ageing population

Risk of Venous thromboembolism higher in ageing population

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

Burden of Diabetic Foot Ulcers

Burden of Diabetic Foot Ulcers

Importance of reducing the risk for Hepatitis C virus infection

Importance of reducing the risk for Hepatitis C virus infection

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

Long-acting therapies are anticipated to drive human immunodeficiency virus (HIV) market, according to a report by...

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Report: Non-alcoholic steatohepatitis market to witness CAGR of 45%

The non-alcoholic steatohepatitis (NASH) market is projected to grow at a compound annual growth rate (CAGR) of 45% from $618m in 2016 to $25.3bn by 2026, according to a report by...

Report: Non-alcoholic steatohepatitis market to witness CAGR of 45%

Report: HIV market to grow marginally at CAGR of 3% by 2025

The human immunodeficiency virus (HIV) market is projected to increase marginally from $16.3bn in 2015 to $22.5bn by 2025, according to a report by...

Report: HIV market to grow marginally at CAGR of 3% by 2025

Report: New standard-of-care maintenance therapies to drive growth of ovarian cancer market to $5.2bn by 2025

The ovarian cancer market is expected to quadruple, increasing from $1.2bn to $5.2bn in value by 2025, according to a report by...

Report: New standard-of-care maintenance therapies to drive growth of ovarian cancer market to $5.2bn by 2025

The need for action: improving awareness and early diagnosis of SLE

The need for action: improving awareness and early diagnosis of SLE

Urban China stands out from US, major European markets and Japan when comparing invasive breast cancer HER2 status

Urban China stands out from US, major European markets and Japan when comparing invasive breast cancer HER2 status

Geographical variations in spondyloarthropathies prevalence related to HLA-B27 Prevalence

Geographical variations in spondyloarthropathies prevalence related to HLA-B27 Prevalence

Report: Cystic fibrosis market to witness double-digit growth up to 2025

Existing and soon to be launched novel, high-priced, disease-modifying cystic fibrosis transmembrane conductance regulator (CFTR) modulators are anticipated to drive the cystic fibrosis market...

Report: Cystic fibrosis market to witness double-digit growth up to 2025